Tmunity Therapeutics, a new Philadelphia company co-founded by immunotherapy pioneer Dr. Carl June of the University of Pennsylvania’s Perelman School of Medicine, raised $10 million in an equity financing from Penn Medicine and venture capital firm Lilly Asia Ventures. Tmunity…

NextCure, Inc., a newly formed biopharmaceutical company focused on the discovery and development of new immuno-oncology products, raised $67m in Series A financing. Backers included Canaan Partners, Lilly Asia Ventures, OrbiMed Advisors, Pfizer, Sofinnova Ventures, and Alexandria Venture Investments. In…